[go: up one dir, main page]

AR066245A1 - Composiciones de fibrina que contienen compuestos de estroncio - Google Patents

Composiciones de fibrina que contienen compuestos de estroncio

Info

Publication number
AR066245A1
AR066245A1 ARP080101685A ARP080101685A AR066245A1 AR 066245 A1 AR066245 A1 AR 066245A1 AR P080101685 A ARP080101685 A AR P080101685A AR P080101685 A ARP080101685 A AR P080101685A AR 066245 A1 AR066245 A1 AR 066245A1
Authority
AR
Argentina
Prior art keywords
compound
fibrine
compositions containing
containing strontium
composition
Prior art date
Application number
ARP080101685A
Other languages
English (en)
Inventor
Stephen E Terry
Gerald Zimmer
John J Barry
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of AR066245A1 publication Critical patent/AR066245A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/225—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/02—Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/28—Bones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/446—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/502—Plasticizers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Composite Materials (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Cardiology (AREA)
  • Botany (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una composicion para su uso en la cicatrizacion osea y la regeneracion osea en la forma de un gel tipo hidrogel viscoelástico o de una formulacion líquida que comprende fibrinogeno, trombina y un componente inorgánico que comprende un compuesto quecontiene estroncio (Sr) y/o posiblemente otro metal tal como un compuesto que contiene calcio. El compuesto que contiene estroncio se puede disolver en las soluciones de trombina o se puede agregar al coágulo en una forma cristalina particulada. Unavez mezclados los componentes, tiene lugar la gelificacion para formar una matriz. La composicion también puede comprender un compuesto que contiene iodo que actua como plastificador.
ARP080101685A 2007-04-23 2008-04-22 Composiciones de fibrina que contienen compuestos de estroncio AR066245A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92571607P 2007-04-23 2007-04-23

Publications (1)

Publication Number Publication Date
AR066245A1 true AR066245A1 (es) 2009-08-05

Family

ID=39745302

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080101685A AR066245A1 (es) 2007-04-23 2008-04-22 Composiciones de fibrina que contienen compuestos de estroncio

Country Status (17)

Country Link
US (1) US20080260714A1 (es)
EP (2) EP2823829B1 (es)
JP (2) JP5907656B2 (es)
KR (1) KR101520114B1 (es)
CN (2) CN101668549B (es)
AR (1) AR066245A1 (es)
AU (1) AU2008242867B2 (es)
BR (1) BRPI0811035B8 (es)
CA (1) CA2686820C (es)
CL (1) CL2008001171A1 (es)
CO (1) CO6251232A2 (es)
ES (2) ES2594081T3 (es)
HK (1) HK1205961A1 (es)
IL (1) IL201480A0 (es)
MX (1) MX2009011268A (es)
TW (1) TWI556842B (es)
WO (1) WO2008131154A2 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1024250C2 (nl) * 2003-09-09 2005-03-10 Fluxxion B V Vervaardiging van een microzeef, en microzeef en inrichting met een microzeef.
US20100284919A1 (en) * 2007-10-12 2010-11-11 Kuros Biosurgery Ag Injectable Radio-Opaque Compositions for Tissue Augmentation
EP2279021B1 (en) 2008-04-18 2013-02-13 Kuros Biosurgery AG Dispensing device, kit containing the device, and method of operating the device
WO2010081044A1 (en) * 2009-01-08 2010-07-15 Numira Biosciences, Inc. Methods and compositions for imaging cartilage and bone
US8467493B2 (en) * 2009-01-08 2013-06-18 Numira Biosciences, Inc. Methods and compositions for imaging atherosclerotic plaques
JP5960051B2 (ja) * 2009-08-04 2016-08-02 プシロクス・エービーＰｓｉｌｏｘ ＡＢ イオン置換リン酸カルシウム粒子
US8882740B2 (en) * 2009-12-23 2014-11-11 Stryker Trauma Gmbh Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone
US8614190B2 (en) 2010-06-30 2013-12-24 Industrial Technology Research Institute Thermal responsive composition for treating bone diseases
WO2012024634A2 (en) * 2010-08-19 2012-02-23 University Of Washington Through Its Center For Commercialization Environmentally-responsive nanocomposites and methods of their use
JP5304939B1 (ja) * 2012-05-31 2013-10-02 大日本印刷株式会社 光学積層体、偏光板、偏光板の製造方法、画像表示装置、画像表示装置の製造方法及び画像表示装置の視認性改善方法
AU2014388246A1 (en) * 2014-03-27 2016-09-01 Novabone Products, Llc Kit for delivering bone grafting materials
ES2802374T3 (es) 2014-06-19 2021-01-19 Consiglio Naz Delle Ricerche C N R Cemento de apatita inyectable de sustitución iónica múltiple para vertebroplastia regenerativa y cifoplastia
US10238507B2 (en) 2015-01-12 2019-03-26 Surgentec, Llc Bone graft delivery system and method for using same
US11559609B2 (en) 2016-12-09 2023-01-24 Northwestern Univesity Bone-promoting thermoresponsive macromolecules
US10687828B2 (en) 2018-04-13 2020-06-23 Surgentec, Llc Bone graft delivery system and method for using same
US11116647B2 (en) 2018-04-13 2021-09-14 Surgentec, Llc Bone graft delivery system and method for using same
EP4467168A1 (en) * 2022-01-18 2024-11-27 Korea Institute of Science and Technology Apatite for filler and filler composition comprising same

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737411A (en) * 1986-11-25 1988-04-12 University Of Dayton Controlled pore size ceramics particularly for orthopaedic and dental applications
US4969888A (en) 1989-02-09 1990-11-13 Arie Scholten Surgical protocol for fixation of osteoporotic bone using inflatable device
IT1240938B (it) 1990-02-08 1993-12-27 S.E.I.P.I. Societa' Esportazione Importazione Prodotti Industriali Composizione vetrosa bioattiva per impianti ossei e prodotti ottenuti con tale composizione o che la comprendono
WO1991017777A2 (en) 1990-05-22 1991-11-28 University Of Florida Injectable bioactive glass compositions and methods for tissue reconstruction
JPH0662381B2 (ja) * 1990-06-26 1994-08-17 昭和薬品化工株式会社 骨性硬組織形成用ペースト組成物
US5206023A (en) * 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
FR2705235B1 (fr) * 1993-05-13 1995-07-13 Inoteb Utilisation de particules d'un sel de calcium biocompatible et biorésorbable comme ingrédient actif dans la préparation d'un médicament destiné au traitement local des maladies déminéralisantes de l'os.
US5549904A (en) 1993-06-03 1996-08-27 Orthogene, Inc. Biological adhesive composition and method of promoting adhesion between tissue surfaces
US6248110B1 (en) * 1994-01-26 2001-06-19 Kyphon, Inc. Systems and methods for treating fractured or diseased bone using expandable bodies
US6241734B1 (en) 1998-08-14 2001-06-05 Kyphon, Inc. Systems and methods for placing materials into bone
FI101129B (sv) 1995-01-13 1998-04-30 Vivoxid Oy Nya bioaktiva glas och deras användning
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
AU4456597A (en) * 1996-09-18 1998-04-14 Basf Aktiengesellschaft Pyridine derivatives, process for preparing the same and their use for controlling animal pests and harmful fungi
JPH10236976A (ja) * 1997-02-26 1998-09-08 Chemo Sero Therapeut Res Inst 骨形成促進剤
US20010016646A1 (en) * 1998-03-20 2001-08-23 David C. Rueger Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
FR2772746B1 (fr) * 1997-12-23 2000-01-28 Commissariat Energie Atomique Procede de fabrication d'une ceramique apatitique, en particulier pour usage biologique
US6258778B1 (en) * 1998-07-13 2001-07-10 University Of Southern California Methods for accelerating bone and cartilage growth and repair
DE19956503A1 (de) * 1999-11-24 2001-06-21 Universitaetsklinikum Freiburg Spritzbares Knochenersatzmaterial
NO20014746D0 (no) * 2001-09-28 2001-09-28 Clas M Kjoelberg Smertelindrende middel
SE522098C2 (sv) 2001-12-20 2004-01-13 Bone Support Ab Ett nytt benmineralsubstitut
US7247288B2 (en) * 2002-04-18 2007-07-24 Carnegie Mellon University Method of manufacturing hydroxyapatite and uses therefor in delivery of nucleic acids
DE10225420A1 (de) * 2002-06-07 2003-12-24 Sanatis Gmbh Strontium-Apatit-Zement-Zubereitungen, die daraus gebildeten Zemente und die Verwendung davon
US7273523B2 (en) * 2002-06-07 2007-09-25 Kyphon Inc. Strontium-apatite-cement-preparations, cements formed therefrom, and uses thereof
DE60210460T2 (de) 2002-10-03 2006-11-23 Vivoxid Oy Bioaktive Glaszusammensetzung
EP1745791B1 (en) * 2003-05-07 2013-06-26 Osteologix A/S Treating cartilage/bone conditions with water-soluble strontium salts
US6905723B2 (en) * 2003-05-30 2005-06-14 Depuy Products, Inc. Strontium-substituted apatite coating
KR100531922B1 (ko) * 2003-12-23 2005-11-29 주식회사 셀론텍 연골치료제 조성물 및 그 사용방법
CA2557324C (en) * 2004-02-26 2012-10-16 Osteologix A/S Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
FR2869544B1 (fr) * 2004-05-03 2006-07-21 Centre Nat Rech Scient Cnrse Composition pour ciment injectable, utile comme substitut osseux
KR20070034075A (ko) * 2004-06-25 2007-03-27 스트론틴 에이피에스 스트론튬과 비타민 ｄ를 함유하는 조성물 및 그의 용도
EP1655042A1 (en) 2004-11-02 2006-05-10 Vivoxid Oy A medical device
ES2902872T3 (es) * 2005-01-06 2022-03-30 Kuros Biosurgery Ag Matrices suplementadas para la reparación de fracturas óseas
US20060216321A1 (en) * 2005-03-24 2006-09-28 Sdgi Holdings, Inc. Solvent based processing technologies for making tissue/polymer composites
CN1846789A (zh) * 2005-04-14 2006-10-18 南方医院 一种注射型骨修复材料及其制备与应用
US9421302B2 (en) * 2006-05-26 2016-08-23 Baxter International Inc. Injectable fibrin composition for bone augmentation
ATE494916T1 (de) * 2006-05-26 2011-01-15 Baxter Int Injizierbarer füllstoff für knochenhohlräume
ES2338694T3 (es) 2006-09-20 2010-05-11 Inion Oy Composiciones de vidrio bioactivo.

Also Published As

Publication number Publication date
JP2013216678A (ja) 2013-10-24
ES2573327T3 (es) 2016-06-07
BRPI0811035B1 (pt) 2018-07-31
CL2008001171A1 (es) 2008-11-03
CO6251232A2 (es) 2011-02-21
TWI556842B (zh) 2016-11-11
CA2686820A1 (en) 2008-10-30
EP2823829B1 (en) 2016-07-20
EP2142224B1 (en) 2016-03-23
WO2008131154A3 (en) 2008-12-24
US20080260714A1 (en) 2008-10-23
CN103785058B (zh) 2016-12-07
KR101520114B1 (ko) 2015-05-13
ES2594081T3 (es) 2016-12-15
TW200902096A (en) 2009-01-16
BRPI0811035B8 (pt) 2021-05-25
CN101668549A (zh) 2010-03-10
EP2142224A2 (en) 2010-01-13
JP6012551B2 (ja) 2016-10-25
EP2823829A1 (en) 2015-01-14
WO2008131154A2 (en) 2008-10-30
IL201480A0 (en) 2010-05-31
AU2008242867B2 (en) 2014-01-23
AU2008242867A1 (en) 2008-10-30
KR20100017158A (ko) 2010-02-16
JP2010525070A (ja) 2010-07-22
BRPI0811035A2 (pt) 2014-10-21
CN101668549B (zh) 2014-04-09
CA2686820C (en) 2016-06-28
HK1205961A1 (zh) 2015-12-31
MX2009011268A (es) 2009-11-02
CN103785058A (zh) 2014-05-14
JP5907656B2 (ja) 2016-04-26

Similar Documents

Publication Publication Date Title
AR066245A1 (es) Composiciones de fibrina que contienen compuestos de estroncio
AR047928A1 (es) Derivados de tetrahidropiridoindol
UY30481A1 (es) Isoxazolinas sustituidas, composiciones farmaccuticas que contienen a las mismas, metodos de preparacion y usos.
NO20064347L (no) Substituerte 1,2,3,4-tetrahydroisokinolinderivater
PE20090605A1 (es) Composiciones de fenilalanina amoniaco-liasa procariotica y metodos del tratamiento del cancer usando composiciones de la misma
CO6290631A2 (es) Composición oral que contiene amino ácidos y un agente blanqueador
CR20150523A (es) Uso de 2,3-dihidroimidazo [1,2-c]quinazolinas sustituidas
BR112015022782A2 (pt) composto, composição farmacêutica, combinação, e, uso de um composto
AR053292A1 (es) Un sistema de suministro para dos o mas componentes acivos como parte de una composicion comestible
GT200600518A (es) Derivados de pirimidina
ATE403469T1 (de) Emboliezusammensetzungen enthaltend pyrogenes silicium
BRPI0515594B8 (pt) compostos inibidores da interação entre mdm2 e p53,composição farmacêutica, processo para a preparação desta composição farmacêutica, usos dos compostos, suas combinações e processo para a preparação destes compostos
CR20120649A (es) Compuestos, composiciones de tioacetato y métodos de uso
DOP2014000133A (es) Triazolopiridinas sustituidas
AR062212A1 (es) Composicion y metodo en relacion con la prevencion y la solucion del dano del gel surfactante
AR061034A1 (es) Alaninas sustituidas con benzoilo
CO6650348A2 (es) Triazolopiridinas sustituidas
HRP20191347T1 (hr) Kirurško ljepilo u kojem su kolagen i fibrin pomiješani i metoda za pripremu istog
AR061054A1 (es) Compuestos acidos de glicerilo y glicol
PA8660601A1 (es) Pirazolopiridinas y sales de las mismas, una composicion farmaceutica que comprende dichos compuestos, un metodo para prepararlos y su uso
EA200970132A1 (ru) Аналоги морфолинила и пирролидинила
EA201370191A1 (ru) КОМПОЗИЦИИ, СОДЕРЖАЩИЕ МОДУЛЯТОРЫ ФАКТОРА КОАГУЛЯЦИИ VIIa, И ИХ ПРИМЕНЕНИЕ
CL2007003042A1 (es) Compuestos derivados del acido tetrahidro-naftalen-1-carboxilico sustituidos con piperidina o piperazina; procedimiento de preparacion; compuesto intermediario; composicion farmaceutica; procedimiento de preparacion; y uso para el tratamiento de arte
EP2653166A3 (en) Pharmaceutical composition and related methods
BR112012007330A2 (pt) compostos, composições contendo os mesmos, uso dos mesmos e processos para a produção dos mesmos.

Legal Events

Date Code Title Description
FB Suspension of granting procedure